Literature DB >> 15994614

A randomized controlled trial comparing fascia lata and synthetic mesh for sacral colpopexy.

Patrick J Culligan1, Linda Blackwell, Linda J Goldsmith, Carol A Graham, Aimee Rogers, Michael H Heit.   

Abstract

OBJECTIVE: To compare the objective anatomic outcomes after sacral colpopexy performed with cadaveric fascia lata and polypropylene mesh.
METHODS: Patients undergoing a sacral colpopexy were randomized to receive either fascia lata or polypropylene mesh in a double-blinded fashion. Data were collected at 6 weeks, 3 months, 6 months, and 1 year postoperatively. The main outcome measures were pelvic organ prolapse quantification (POP-Q) system stage and individual POP-Q points over time. Objective anatomic failure was defined as POP-Q stage 2 or more at any point during the follow-up period. Proportions of patients with objective anatomic failure at 1 year in each group were compared using the chi(2) test. Mean POP-Q points and stage at 1 year were compared by using the independent samples t test.
RESULTS: One hundred patients were randomized to receive either fascia (n = 46) or mesh (n = 54). Of the 89 patients returning for 1-year follow-up, 91% (41/45) of the mesh group and 68% (30/44) of the fascia group were classified as objectively cured (P = .007). We found significant differences between the mesh and fascia groups with respect to the 1-year postoperative comparisons of points Aa, C, and POP-Q stage. There were no differences between the 2 groups with respect to points TVL (total vaginal length), GH (genital hiatus), PB (perineal body), Ap or Bp (2 points along the posterior vaginal wall).
CONCLUSIONS: Polypropylene mesh was superior to fascia lata in terms of POP-Q points, POP-Q stage, and objective anatomic failure rates. LEVEL OF EVIDENCE: I.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15994614     DOI: 10.1097/01.AOG.0000165824.62167.c1

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  39 in total

Review 1.  Evaluation of current biologic meshes in pelvic organ prolapse repair.

Authors:  Ashley Cox; Sender Herschorn
Journal:  Curr Urol Rep       Date:  2012-06       Impact factor: 3.092

Review 2.  Systematic review of the efficacy and safety of using mesh in surgery for uterine or vaginal vault prolapse.

Authors:  Xueli Jia; Cathryn Glazener; Graham Mowatt; David Jenkinson; Cynthia Fraser; Christine Bain; Jennifer Burr
Journal:  Int Urogynecol J       Date:  2010-06-15       Impact factor: 2.894

3.  Cadaveric fascia lata.

Authors:  Pamela A Moalli
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-06

Review 4.  Abdominal sacral colpopexy: surgical pearls and outcomes.

Authors:  Anthony J Woodruff; Christopher C Roth; J Christian Winters
Journal:  Curr Urol Rep       Date:  2007-09       Impact factor: 3.092

5.  [Vaginal descensus and prolapse. Which operative technique?].

Authors:  M F Hamann; C Seif
Journal:  Urologe A       Date:  2009-05       Impact factor: 0.639

Review 6.  Complications of pelvic organ prolapse surgery and methods of prevention.

Authors:  Renaud de Tayrac; Loic Sentilhes
Journal:  Int Urogynecol J       Date:  2013-11       Impact factor: 2.894

7.  Management of complications arising from transvaginal mesh kit procedures: a tertiary referral center's experience.

Authors:  Eric A Hurtado; Rodney A Appell
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-09-20

8.  Robotic-assisted laparoscopic mesh sacrocolpopexy.

Authors:  Jason P Gilleran; Matthew Johnson; Andrew Hundley
Journal:  Ther Adv Urol       Date:  2010-10

9.  A rat hysteropexy model for evaluating adhesion formation and comparison of two different structured meshes.

Authors:  Ayse Filiz Gokmen-Karasu; Serdar Aydin; Fatma Cavide Sonmez; Ilknur Adanir; Gulsah Ilhan; Seda Ates
Journal:  Int Urogynecol J       Date:  2017-04-24       Impact factor: 2.894

10.  Polypropylene as a reinforcement in pelvic surgery is not inert: comparative analysis of 100 explants.

Authors:  Arnaud Clavé; Hannah Yahi; Jean-Claude Hammou; Suzelei Montanari; Pierre Gounon; Henri Clavé
Journal:  Int Urogynecol J       Date:  2010-01-06       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.